Proving SGLT2 Inhibitor-Mediated Improvement in Cardiomyocyte Energetics: Beyond a Reasonable Doubt?

Mallory Filipp; Sanjiv J. Shah

doi:10.1161/CIRCHEARTFAILURE.124.011646

Proving SGLT2 Inhibitor-Mediated Improvement in Cardiomyocyte Energetics: Beyond a Reasonable Doubt?

Mallory Filipp, Sanjiv J. Shah^*

^*Corresponding author for this work

Medicine, Cardiology Division

Research output: Contribution to journal › Editorial › peer-review

Original language	English (US)
Pages (from-to)	e011646
Journal	Circulation: Heart Failure
Volume	17
Issue number	6
DOIs	https://doi.org/10.1161/CIRCHEARTFAILURE.124.011646
State	Published - Jun 1 2024

Funding

M. Filipp and Dr Shah are supported by grants from the National Institutes of Health (F31 HL156408 to M. Filipp; and U54 HL160273, X01 HL169712, R01 HL140731, and R01 HL149423 to Dr Shah).

Keywords

Editorials
heart failure metabolic disease
molecular mechanisms of pharmacological action
sodium-glucose transporter 2

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1161/CIRCHEARTFAILURE.124.011646

Cite this

@article{18c9165e87be40848a820d9c132af66e,

title = "Proving SGLT2 Inhibitor-Mediated Improvement in Cardiomyocyte Energetics: Beyond a Reasonable Doubt?",

keywords = "Editorials, heart failure metabolic disease, molecular mechanisms of pharmacological action, sodium-glucose transporter 2",

author = "Mallory Filipp and Shah, {Sanjiv J.}",

year = "2024",

month = jun,

day = "1",

doi = "10.1161/CIRCHEARTFAILURE.124.011646",

language = "English (US)",

volume = "17",

pages = "e011646",

journal = "Circulation: Heart Failure",

issn = "1941-3289",

publisher = "Lippincott Williams and Wilkins",

number = "6",

}

TY - JOUR

T1 - Proving SGLT2 Inhibitor-Mediated Improvement in Cardiomyocyte Energetics

T2 - Beyond a Reasonable Doubt?

AU - Filipp, Mallory

AU - Shah, Sanjiv J.

PY - 2024/6/1

Y1 - 2024/6/1

KW - Editorials

KW - heart failure metabolic disease

KW - molecular mechanisms of pharmacological action

KW - sodium-glucose transporter 2

UR - http://www.scopus.com/inward/record.url?scp=85196160898&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85196160898&partnerID=8YFLogxK

U2 - 10.1161/CIRCHEARTFAILURE.124.011646

DO - 10.1161/CIRCHEARTFAILURE.124.011646

M3 - Editorial

C2 - 38847114

AN - SCOPUS:85196160898

SN - 1941-3289

VL - 17

SP - e011646

JO - Circulation: Heart Failure

JF - Circulation: Heart Failure

IS - 6

ER -

Proving SGLT2 Inhibitor-Mediated Improvement in Cardiomyocyte Energetics: Beyond a Reasonable Doubt?

Funding

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this